Abstract
The St. Jude Medical Trifecta aortic supra-annular bioprosthesis is regarded as the next generation in pericardial stented tissue valves. The unique design of tissue leaflets attached to the exterior of the valve stent provides unrivalled in-vivo mean gradients and haemodynamics.
Highlights
Midterm Follow-Up of Haemodynamic Performance of the St. Jude Medical Trifecta Aortic Bioprosthesis in Young Patients Under 65
The unique design of tissue leaflets attached to the exterior of the valve stent provides unrivalled in-vivo mean gradients and haemodynamics
Aims/Objectives The aim of this prospective study was to evaluate midterm haemodynamic performance of valve implanted into patients under 65
Summary
Midterm Follow-Up of Haemodynamic Performance of the St. Jude Medical Trifecta Aortic Bioprosthesis in Young Patients Under 65 JA Chacko, J Edlin, AH Sepehripour, SG Ambekar, KS Lall* From World Society of Cardiothoracic Surgeons 25th Anniversary Congress, Edinburgh Edinburgh, UK. Background/Introduction The St. Jude Medical Trifecta aortic supra-annular bioprosthesis is regarded as the generation in pericardial stented tissue valves.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
